Tumor |
Total Positive Rate |
Ovarian Cancer |
80% |
Gastric Cancer |
63% |
Cervical Cancer |
79% |
Pancreatic Cancer |
96% |
Hepatocellular Cancer |
88% |
Lung Cancer |
80% |
Prostate Cancer |
73% |
Test Kit |
Target Diseases |
Time |
False Positive |
False Negative |
AFP |
Hepatocellular Cancer |
1 hr |
10% |
35% |
PSA |
Prostate Cancer |
2 hr |
15% |
14% |
CA 125 |
Ovarian Cancer |
1 hr |
14% |
18% |
NSE |
Lung Cancer |
1 hr |
18% |
23% |
Biomarkers C12 |
Several Tumors |
42 samples / 3 hr |
1-10% |
6-20% |
 |
| | Home | Contact Us | Technical Info | Logon | |
| Clinical Data More than 6,000 clinical data has been studied, showing great value of Biomarkers C12 Protein Chip for multi-tumor marker detection. |
| |
Copyright Biomarkers 2005 |